Follistatin in chondrocytes

The link between TRPV4 channelopathies and skeletal malformations

Holly A. Leddy, Amy L. McNulty, Nicole E. Rothfusz, Farshid Guilak, Suk-Hee Lee, Bernd Gloss, Margaret L. Kirby, Mary R. Hutson, Daniel H. Cohn, Wolfgang Liedtke

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Point mutations in the calcium-permeable TRPV4 ion channel have been identified as the cause of autosomal-dominant human motor neuropathies, arthropathies, and skeletal malformations of varying severity. The objective of this study was to determine the mechanism by which TRPV4 channelopathy mutations cause skeletal dysplasia. The human TRPV4V620I channelopathy mutation was transfected into primary porcine chondrocytes and caused significant (2.6-fold) up-regulation of follistatin (FST) expression levels. Pore altering mutations that prevent calcium influx through the channel prevented significant FST up-regulation (1.1-fold). We generated a mouse model of theTRPV4V620I mutation, and found significant skeletal deformities (e.g., shortening of tibiae and digits, similar to the human disease brachyolmia) and increases in Fst/TRPV4 mRNA levels (2.8-fold). FST was significantly up-regulated in primary chondrocytes transfected with 3 different dysplasia-causing TRPV4 mutations (2- to 2.3-fold), but was not affected by an arthropathy mutation (1.1-fold). Furthermore, FST-loaded microbeads decreased bone ossification in developing chick femora (6%) and tibiae (11%). FST gene and protein levels were also increased 4-fold in human chondrocytes from an individual natively expressing the TRPV4T89I mutation. Taken together, these data strongly support that up-regulation of FST in chondrocytes by skeletal dysplasia-inducing TRPV4 mutations contributes to disease pathogenesis.

Original languageEnglish (US)
Pages (from-to)2525-2537
Number of pages13
JournalFASEB Journal
Volume28
Issue number6
DOIs
StatePublished - Jan 1 2014
Externally publishedYes

Fingerprint

Channelopathies
Follistatin
Chondrocytes
Mutation
Up-Regulation
Joint Diseases
Tibia
Calcium
Ion Channels
Bone
Microspheres
Point Mutation
Osteogenesis
Femur
Messenger RNA
Swine
Bone and Bones

Keywords

  • Bone morphogenetic protein
  • Calcium signaling
  • Cartilage
  • Growth plate

ASJC Scopus subject areas

  • Biotechnology
  • Biochemistry
  • Molecular Biology
  • Genetics

Cite this

Leddy, H. A., McNulty, A. L., Rothfusz, N. E., Guilak, F., Lee, S-H., Gloss, B., ... Liedtke, W. (2014). Follistatin in chondrocytes: The link between TRPV4 channelopathies and skeletal malformations. FASEB Journal, 28(6), 2525-2537. https://doi.org/10.1096/fj.13-245936

Follistatin in chondrocytes : The link between TRPV4 channelopathies and skeletal malformations. / Leddy, Holly A.; McNulty, Amy L.; Rothfusz, Nicole E.; Guilak, Farshid; Lee, Suk-Hee; Gloss, Bernd; Kirby, Margaret L.; Hutson, Mary R.; Cohn, Daniel H.; Liedtke, Wolfgang.

In: FASEB Journal, Vol. 28, No. 6, 01.01.2014, p. 2525-2537.

Research output: Contribution to journalArticle

Leddy, HA, McNulty, AL, Rothfusz, NE, Guilak, F, Lee, S-H, Gloss, B, Kirby, ML, Hutson, MR, Cohn, DH & Liedtke, W 2014, 'Follistatin in chondrocytes: The link between TRPV4 channelopathies and skeletal malformations', FASEB Journal, vol. 28, no. 6, pp. 2525-2537. https://doi.org/10.1096/fj.13-245936
Leddy HA, McNulty AL, Rothfusz NE, Guilak F, Lee S-H, Gloss B et al. Follistatin in chondrocytes: The link between TRPV4 channelopathies and skeletal malformations. FASEB Journal. 2014 Jan 1;28(6):2525-2537. https://doi.org/10.1096/fj.13-245936
Leddy, Holly A. ; McNulty, Amy L. ; Rothfusz, Nicole E. ; Guilak, Farshid ; Lee, Suk-Hee ; Gloss, Bernd ; Kirby, Margaret L. ; Hutson, Mary R. ; Cohn, Daniel H. ; Liedtke, Wolfgang. / Follistatin in chondrocytes : The link between TRPV4 channelopathies and skeletal malformations. In: FASEB Journal. 2014 ; Vol. 28, No. 6. pp. 2525-2537.
@article{fc90440f572d4927bd3794b0f9c5143f,
title = "Follistatin in chondrocytes: The link between TRPV4 channelopathies and skeletal malformations",
abstract = "Point mutations in the calcium-permeable TRPV4 ion channel have been identified as the cause of autosomal-dominant human motor neuropathies, arthropathies, and skeletal malformations of varying severity. The objective of this study was to determine the mechanism by which TRPV4 channelopathy mutations cause skeletal dysplasia. The human TRPV4V620I channelopathy mutation was transfected into primary porcine chondrocytes and caused significant (2.6-fold) up-regulation of follistatin (FST) expression levels. Pore altering mutations that prevent calcium influx through the channel prevented significant FST up-regulation (1.1-fold). We generated a mouse model of theTRPV4V620I mutation, and found significant skeletal deformities (e.g., shortening of tibiae and digits, similar to the human disease brachyolmia) and increases in Fst/TRPV4 mRNA levels (2.8-fold). FST was significantly up-regulated in primary chondrocytes transfected with 3 different dysplasia-causing TRPV4 mutations (2- to 2.3-fold), but was not affected by an arthropathy mutation (1.1-fold). Furthermore, FST-loaded microbeads decreased bone ossification in developing chick femora (6{\%}) and tibiae (11{\%}). FST gene and protein levels were also increased 4-fold in human chondrocytes from an individual natively expressing the TRPV4T89I mutation. Taken together, these data strongly support that up-regulation of FST in chondrocytes by skeletal dysplasia-inducing TRPV4 mutations contributes to disease pathogenesis.",
keywords = "Bone morphogenetic protein, Calcium signaling, Cartilage, Growth plate",
author = "Leddy, {Holly A.} and McNulty, {Amy L.} and Rothfusz, {Nicole E.} and Farshid Guilak and Suk-Hee Lee and Bernd Gloss and Kirby, {Margaret L.} and Hutson, {Mary R.} and Cohn, {Daniel H.} and Wolfgang Liedtke",
year = "2014",
month = "1",
day = "1",
doi = "10.1096/fj.13-245936",
language = "English (US)",
volume = "28",
pages = "2525--2537",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "6",

}

TY - JOUR

T1 - Follistatin in chondrocytes

T2 - The link between TRPV4 channelopathies and skeletal malformations

AU - Leddy, Holly A.

AU - McNulty, Amy L.

AU - Rothfusz, Nicole E.

AU - Guilak, Farshid

AU - Lee, Suk-Hee

AU - Gloss, Bernd

AU - Kirby, Margaret L.

AU - Hutson, Mary R.

AU - Cohn, Daniel H.

AU - Liedtke, Wolfgang

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Point mutations in the calcium-permeable TRPV4 ion channel have been identified as the cause of autosomal-dominant human motor neuropathies, arthropathies, and skeletal malformations of varying severity. The objective of this study was to determine the mechanism by which TRPV4 channelopathy mutations cause skeletal dysplasia. The human TRPV4V620I channelopathy mutation was transfected into primary porcine chondrocytes and caused significant (2.6-fold) up-regulation of follistatin (FST) expression levels. Pore altering mutations that prevent calcium influx through the channel prevented significant FST up-regulation (1.1-fold). We generated a mouse model of theTRPV4V620I mutation, and found significant skeletal deformities (e.g., shortening of tibiae and digits, similar to the human disease brachyolmia) and increases in Fst/TRPV4 mRNA levels (2.8-fold). FST was significantly up-regulated in primary chondrocytes transfected with 3 different dysplasia-causing TRPV4 mutations (2- to 2.3-fold), but was not affected by an arthropathy mutation (1.1-fold). Furthermore, FST-loaded microbeads decreased bone ossification in developing chick femora (6%) and tibiae (11%). FST gene and protein levels were also increased 4-fold in human chondrocytes from an individual natively expressing the TRPV4T89I mutation. Taken together, these data strongly support that up-regulation of FST in chondrocytes by skeletal dysplasia-inducing TRPV4 mutations contributes to disease pathogenesis.

AB - Point mutations in the calcium-permeable TRPV4 ion channel have been identified as the cause of autosomal-dominant human motor neuropathies, arthropathies, and skeletal malformations of varying severity. The objective of this study was to determine the mechanism by which TRPV4 channelopathy mutations cause skeletal dysplasia. The human TRPV4V620I channelopathy mutation was transfected into primary porcine chondrocytes and caused significant (2.6-fold) up-regulation of follistatin (FST) expression levels. Pore altering mutations that prevent calcium influx through the channel prevented significant FST up-regulation (1.1-fold). We generated a mouse model of theTRPV4V620I mutation, and found significant skeletal deformities (e.g., shortening of tibiae and digits, similar to the human disease brachyolmia) and increases in Fst/TRPV4 mRNA levels (2.8-fold). FST was significantly up-regulated in primary chondrocytes transfected with 3 different dysplasia-causing TRPV4 mutations (2- to 2.3-fold), but was not affected by an arthropathy mutation (1.1-fold). Furthermore, FST-loaded microbeads decreased bone ossification in developing chick femora (6%) and tibiae (11%). FST gene and protein levels were also increased 4-fold in human chondrocytes from an individual natively expressing the TRPV4T89I mutation. Taken together, these data strongly support that up-regulation of FST in chondrocytes by skeletal dysplasia-inducing TRPV4 mutations contributes to disease pathogenesis.

KW - Bone morphogenetic protein

KW - Calcium signaling

KW - Cartilage

KW - Growth plate

UR - http://www.scopus.com/inward/record.url?scp=84901838409&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901838409&partnerID=8YFLogxK

U2 - 10.1096/fj.13-245936

DO - 10.1096/fj.13-245936

M3 - Article

VL - 28

SP - 2525

EP - 2537

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 6

ER -